Industry Growth Insights published a new data on “Transdermal Skin Patches Market”. The research report is titled “Transdermal Skin Patches Market research by Types (Drug in Adhesive, Matrix, Reservoir, Vapor, Others), By Applications (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Players/Companies Johnson & Johnson, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries, Luye Pharma Group, Hisamitsu Pharmaceutical, Mundipharma International, Purdue Pharma, Johnson & Johnson”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Transdermal Skin Patches Market Research Report
By Type
Drug in Adhesive, Matrix, Reservoir, Vapor, Others
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Johnson & Johnson, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries, Luye Pharma Group, Hisamitsu Pharmaceutical, Mundipharma International, Purdue Pharma, Johnson & Johnson
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
210
Number of Tables & Figures
147
Customization Available
Yes, the report can be customized as per your need.
Global Transdermal Skin Patches Market Report Segments:
The global Transdermal Skin Patches market is segmented on the basis of:
Types
Drug in Adhesive, Matrix, Reservoir, Vapor, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Johnson & Johnson
- Novartis AG
- Mylan N.V.
- Teva Pharmaceutical Industries
- Luye Pharma Group
- Hisamitsu Pharmaceutical
- Mundipharma International
- Purdue Pharma
- Johnson & Johnson
Highlights of The Transdermal Skin Patches Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Drug in Adhesive
- Matrix
- Reservoir
- Vapor
- Others
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Transdermal Skin Patches Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Transdermal skin patches are a type of medication that are placed on the skin and release the drug into the body through the skin. The patch is changed every day, and it usually takes about two weeks for the drug to be fully absorbed by your body. Transdermal patches can be used to treat a variety of conditions, including pain relief, anxiety disorders, depression, and chronic pain.
Some of the major companies in the transdermal skin patches market are Johnson & Johnson, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries, Luye Pharma Group, Hisamitsu Pharmaceutical, Mundipharma International, Purdue Pharma, Johnson & Johnson.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Transdermal Skin Patches Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Transdermal Skin Patches Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Transdermal Skin Patches Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Transdermal Skin Patches Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Transdermal Skin Patches Market Size & Forecast, 2018-2028
4.5.1 Transdermal Skin Patches Market Size and Y-o-Y Growth
4.5.2 Transdermal Skin Patches Market Absolute $ Opportunity
Chapter 5 Global Transdermal Skin Patches Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Transdermal Skin Patches Market Size Forecast by Type
5.2.1 Drug in Adhesive
5.2.2 Matrix
5.2.3 Reservoir
5.2.4 Vapor
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Transdermal Skin Patches Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Transdermal Skin Patches Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Transdermal Skin Patches Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Transdermal Skin Patches Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Transdermal Skin Patches Analysis and Forecast
9.1 Introduction
9.2 North America Transdermal Skin Patches Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Transdermal Skin Patches Market Size Forecast by Type
9.6.1 Drug in Adhesive
9.6.2 Matrix
9.6.3 Reservoir
9.6.4 Vapor
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Transdermal Skin Patches Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Online Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Transdermal Skin Patches Analysis and Forecast
10.1 Introduction
10.2 Europe Transdermal Skin Patches Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Transdermal Skin Patches Market Size Forecast by Type
10.6.1 Drug in Adhesive
10.6.2 Matrix
10.6.3 Reservoir
10.6.4 Vapor
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Transdermal Skin Patches Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Transdermal Skin Patches Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Transdermal Skin Patches Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Transdermal Skin Patches Market Size Forecast by Type
11.6.1 Drug in Adhesive
11.6.2 Matrix
11.6.3 Reservoir
11.6.4 Vapor
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Transdermal Skin Patches Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Transdermal Skin Patches Analysis and Forecast
12.1 Introduction
12.2 Latin America Transdermal Skin Patches Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Transdermal Skin Patches Market Size Forecast by Type
12.6.1 Drug in Adhesive
12.6.2 Matrix
12.6.3 Reservoir
12.6.4 Vapor
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Transdermal Skin Patches Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Transdermal Skin Patches Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Transdermal Skin Patches Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Transdermal Skin Patches Market Size Forecast by Type
13.6.1 Drug in Adhesive
13.6.2 Matrix
13.6.3 Reservoir
13.6.4 Vapor
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Transdermal Skin Patches Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Transdermal Skin Patches Market: Competitive Dashboard
14.2 Global Transdermal Skin Patches Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Johnson & Johnson
14.3.2 Novartis AG
14.3.3 Mylan N.V.
14.3.4 Teva Pharmaceutical Industries
14.3.5 Luye Pharma Group
14.3.6 Hisamitsu Pharmaceutical
14.3.7 Mundipharma International
14.3.8 Purdue Pharma
14.3.9 Johnson & Johnson
